Systemic and renal lipids in kidney disease development and progression

Patricia Wahl, Gloria Michelle Ducasa, Alessia Fornoni

Research output: Contribution to journalReview articlepeer-review

50 Scopus citations


Altered lipid metabolism characterizes proteinuria and chronic kidney diseases. While it is thought that dyslipidemia is a consequence of kidney disease, a large body of clinical and experimental studies support that altered lipid metabolism may contribute to the pathogenesis and progression of kidney disease. In fact, accumulation of renal lipids has been observed in several conditions of genetic and nongenetic origins, linking local fat to the pathogenesis of kidney disease. Statins, which target cholesterol synthesis, have not been proven beneficial to slow the progression of chronic kidney disease. Therefore, other therapeutic strategies to reduce cholesterol accumulation in peripheral organs, such as the kidney, warrant further investigation. Recent advances in the understanding of the biology of high-density lipoprotein (HDL) have revealed that functional HDL, rather than total HDL per se, may protect from both cardiovascular and kidney diseases, strongly supporting a role for altered cholesterol efflux in the pathogenesis of kidney disease. Although the underlying pathophysiological mechanisms responsible for lipid-induced renal damage have yet to be uncovered, several studies suggest novel mechanisms by which cholesterol, free fatty acids, and sphingolipids may affect glomerular and tubular cell function. This review will focus on the clinical and experimental evidence supporting a causative role of lipids in the pathogenesis of proteinuria and kidney disease, with a primary focus on podocytes.

Original languageEnglish (US)
Pages (from-to)F433-F445
JournalAmerican Journal of Physiology - Renal Physiology
Issue number6
StatePublished - Mar 15 2016


  • Cholesterol
  • Dyslipidemia
  • Kidney disease
  • Lipids
  • Podocytes

ASJC Scopus subject areas

  • Physiology
  • Urology


Dive into the research topics of 'Systemic and renal lipids in kidney disease development and progression'. Together they form a unique fingerprint.

Cite this